Skip to content
healthcare.dev

Telmisartan and Hydrochlorothiazide

NDC 68180-193, Telmisartan and Hydrochlorothiazide, tablet, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-193
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091351
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-193 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCHLOROTHIAZIDE12.5 mg/1
  • TELMISARTAN40 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b88054b3-fafa-4b4e-acf5-5294e5555720

Use it

Look up 68180-193 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-193 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.